Diaverum France
Diaverum France operates 18-19 dialysis clinics serving approximately 2,000 chronic kidney disease patients with 700+ employees, delivering hemodialysis, peritoneal dialysis, and transplantation support reimbursed through the French national health system as part of the M42-owned Diaverum network.
- Company typePrivate
- Founded1991
- HeadquartersLyon, France
- Headcount—
- GTM typeB2C
- OfferingServices
What Diaverum France does
Diaverum France is the French operating subsidiary of Sweden-headquartered Diaverum AB, itself a member of the M42 group following a 2023 ownership change. Founded locally in 2008, Diaverum France operates 18-19 nephrology and dialysis clinics distributed across the Ile-de-France, PACA, and eastern and western regions of France, employing more than 700 collaborators and serving nearly 2,000 chronic kidney disease (CKD) patients. The organization is the largest independent nephrology care provider in Europe and functions as a regional execution arm of a 469-clinic, 24-country global network that delivers approximately 6.5 million dialysis treatments annually to 42,700 patients worldwide.
The company's clinical services span hemodialysis (in-clinic and at-home), peritoneal dialysis (continuous ambulatory and automated), and kidney transplantation preparation and follow-up care. These clinical services are supported by an integrated proprietary digital stack: d.CARE for patient and clinic management, TGS for tablet-based treatment monitoring, PGS for pharmacological management, d.CONNECT for automated device data capture, and d.ACADEMY for staff training. Patient-facing tools include the d.CARE mobile app for iOS/Android, the d.HOLIDAY vacation dialysis booking platform (powered by bookdialysis.com integration), and the 2025-launched kidney.com AI assistant for renal health education. Clinical quality is governed by the Clinical Performance Metrics (CPM) system, and the company was awarded 100% HAS certification across its French centers in the 2023-2025 cycle, with 15 of 19 centers earning the top-tier 'Haute Qualité des Soins' designation.
Diaverum France generates revenue through fee-for-service nephrology care reimbursed primarily by the French national health system (Sécurité sociale) and complementary insurance; specific tariffs are not publicly disclosed. Patient acquisition occurs via physician referral, the company's online clinic finder (with geolocation), and self-serve booking through d.HOLIDAY. Distribution is anchored by direct ownership of physical clinic assets, each typically containing 16-20+ dialysis stations, with the Paris Jaurès clinic (opened April 2023, 1,000+ m2, 16 stations, capacity for 80 patients) representing the most recent capacity expansion. The strategic direction is increasingly shaped by parent M42's AI and data capabilities, which underwrite the kidney.com product roadmap and broader digital health ambitions.
Diaverum France firmographics
Firmographics- Name
- Diaverum France
- Legal name
- Diaverum AB
- Website
- https://diaverum.fr
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Short description
- Diaverum France operates 18-19 dialysis clinics serving approximately 2,000 chronic kidney disease patients with 700+ employees, delivering hemodialysis, peritoneal dialysis, and transplantation support reimbursed through the French national health system as part of the M42-owned Diaverum network.
- Ownership category
- akta.pro rank
Diaverum France industry classification
Industry- Product category
- Dialysis & Nephrology Care Services
- NAICS
- Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)
- akta.pro secondary industry
- Nephrology Telemedicine Platforms (HLALAGAI)
Keywords
Where Diaverum France is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Diaverum France business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Nephrology Care Services: Diaverum generates revenue through providing nephrology care services including hemodialysis, peritoneal dialysis, and related treatments to patients with chronic kidney disease. Services are delivered through a network of clinics and are typically reimbursed through national health systems or insurance.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Diaverum France product offering
Product offeringCore offering
Diaverum France provides comprehensive nephrology care to patients with chronic kidney disease through its network of 18 dialysis clinics across France, offering hemodialysis, peritoneal dialysis, and kidney transplantation preparation and follow-up services. The company serves nearly 2,000 patients with over 700 collaborators and is part of the global Diaverum network operating 469 clinics across 24 countries. Care is delivered through proprietary digital platforms (d.CARE, TGS, PGS, d.CONNECT) and patient-facing tools including the kidney.com AI health assistant and d.HOLIDAY vacation dialysis program.
Product overview
Diaverum France offers a comprehensive nephrology care ecosystem combining clinical services with proprietary digital platforms. The core clinical services include hemodialysis, peritoneal dialysis, and kidney transplantation support. These are supported by an integrated digital portfolio: d.CARE serves as the central patient and clinic management platform, connected to TGS (treatment monitoring), PGS (pharmacological management), and d.CONNECT (automated data collection from dialysis equipment). Patient-facing digital tools include the d.CARE mobile app for iOS/Android, kidney.com AI health assistant, and the d.HOLIDAY vacation dialysis program with online booking. Staff development is supported by d.ACADEMY virtual training platform. Quality monitoring uses the Clinical Performance Metrics (CPM) system, with the MyDiaverumExperience portal enabling patient feedback collection.
Differentiator
Problem solved
Functional benefit
Brands
- d.HOLIDAY: Diaverum's vacation dialysis program that enables dialysis patients to travel and receive treatment at clinics within the company's global network of 469 clinics across 24 countries.
- d.CARE
- d.ACADEMY
- d.CONNECT
- kidney.com
Products and services
- Hemodialysis Blood purification treatment that eliminates toxic substances accumulated in the blood, performed in clinic or at home. Removes waste and excess water from the body through a dialyzer with semi-permeable membranes. Delivered to chronic kidney disease patients across Diaverum France's 18 dialysis clinics.
- Peritoneal Dialysis Renal replacement therapy performed inside the body without external blood circulation. Can be performed at home as Continuous Ambulatory Peritoneal Dialysis (3-5 daily exchanges) or Automated Peritoneal Dialysis (overnight via cycler machine). Offered to chronic kidney disease patients in France.
- Kidney Transplantation Support Surgical treatment for kidney failure including preparation support and post-transplant follow-up care. Diaverum France provides pre-transplant preparation and post-transplant monitoring for patients awaiting or recovering from kidney transplantation.
- d.HOLIDAY Vacation Dialysis Program Vacation dialysis program enabling dialysis patients to travel by providing access to high-quality nephrology care across Diaverum's global network of 469 clinics in 24 countries. Includes online booking platform, travel guides, and emergency return program for transplant-eligible patients traveling in Europe. Available to dialysis patients in France seeking to travel.
- kidney.com AI Health Assistant AI-powered digital health assistant based on artificial intelligence for renal health education. Provides accessible, reliable, and personalized education on chronic kidney disease through conversational AI, voice interaction, and multilingual support. Free to users.
Quantifiable outcome
- 100% of Diaverum France centers certified by HAS with compliance scores between 96.8% and 99%
- +2 more outcomes
Companies that use Diaverum France
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Diaverum France technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability6 records
Feature7 records
Diaverum France partnerships and signals
Strategic signalScale indicators8 records
Recent moves7 records
Expansion highlights5 records
Diaverum France competitors and assessment
Company assessmentDirect peers
- Fresenius Medical Care: World's largest dialysis services and products company, operating thousands of clinics globally including in France. Directly competes with Diaverum France in outpatient hemodialysis and peritoneal dialysis, and benefits from vertical integration into equipment manufacturing.
- B. Braun Avitum: Dialysis services division of B. Braun, one of Europe's largest medical device and healthcare services groups. Operates dialysis centers across Europe and competes head-to-head with Diaverum in France and other European markets.
Broad incumbents
- DaVita: Leading US-headquartered dialysis services operator with ~3,000 clinics. While US-centric, DaVita is a structural global benchmark for clinic-level operations, care model standardization, and value-based care contracting relevant to Diaverum France's parent network.
Others
- Diaverum AB: Parent entity of Diaverum France; provides strategic context on group-level scale (469 clinics, 24 countries). Same company, so not a competitor, but serves as the natural benchmark for French-subsidiary performance versus the wider portfolio.
Emerging players
- NephroPlus: Asia's largest dialysis network operator headquartered in India. While geographically distant, NephroPlus is comparable in clinic-network scaling strategy and is an emerging challenger to Western incumbents in emerging-market dialysis.
Regional players
- U.S. Renal Care: US-based mid-sized dialysis services operator with several hundred clinics. Operates a comparable outpatient clinic model and competes in similar value-based-care contracting environments, providing US benchmark data relevant to France.
- Satellite Healthcare: US non-profit dialysis provider focused on patient outcomes and quality. Comparable operating model and emphasis on clinical quality metrics, making it a useful reference for outcomes-driven dialysis operations.
- American Renal Associates: US-based dialysis services provider operating in outpatient settings. Comparable clinic-based operating model; relevant as a regional scale benchmark outside France.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Diaverum France social profiles
Digital presenceDiaverum France compliance and trust
Trust signalCompliance1 record
Diaverum France financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diaverum France leadership team
Management profileNumber of profiles
Profiles9 records
Diaverum France subsidiaries and ownership
Company hierarchySubsidiaries18 records
Diaverum France funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diaverum France M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diaverum France
What does Diaverum France do?
Diaverum France provides comprehensive nephrology care to patients with chronic kidney disease through its network of 18 dialysis clinics across France, offering hemodialysis, peritoneal dialysis, and kidney transplantation preparation and follow-up services. The company serves nearly 2,000 patients with over 700 collaborators and is part of the global Diaverum network operating 469 clinics across 24 countries. Care is delivered through proprietary digital platforms (d.CARE, TGS, PGS, d.CONNECT) and patient-facing tools including the kidney.com AI health assistant and d.HOLIDAY vacation dialysis program.
Is Diaverum France a public or private company?
Diaverum France is a private company. It is classified as corporate owned and is currently operating.
When was Diaverum France founded?
Diaverum France was founded in 1991.
Where is Diaverum France based?
Diaverum France is headquartered in Lyon, France, in the Europe region.
How does Diaverum France make money?
One revenue line is on record: nephrology Care Services.
Who are Diaverum France's main competitors?
Direct peers on record are Fresenius Medical Care and B. Braun Avitum. DaVita is listed as a broad incumbent. Diaverum AB is listed as an others. NephroPlus is listed as an emerging player. Regional players are U.S. Renal Care, Satellite Healthcare and American Renal Associates.
Does Diaverum France have an API?
No public API is recorded for Diaverum France.
What industry is Diaverum France in?
Diaverum France's product category is Dialysis & Nephrology Care Services. Its primary akta.pro industry code is HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis), with a secondary code of HLALAGAI, Nephrology Telemedicine Platforms. Its NAICS code is 621492 and its SIC code is 8011.